Endophthalmitis after uncomplicated cataract surgery with the use of fourth-generation fluoroquinolones: a retrospective observational case series.
暂无分享,去创建一个
[1] G. Gettinby,et al. ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Preliminary report of principal results from a European multicenter study , 2006, Journal of cataract and refractive surgery.
[2] M. Moshirfar,et al. Fourth-generation fluoroquinolone-resistant bacterial keratitis after refractive surgery. , 2006, Journal of cataract and refractive surgery.
[3] J. Blondeau,et al. Future of ophthalmic anti-infective therapy and the role of moxifloxacin ophthalmic solution 0.5% (VIGAMOX). , 2005, Survey of ophthalmology.
[4] J. Dick,et al. Aqueous penetration and biological activity of moxifloxacin 0.5% ophthalmic solution and gatifloxacin 0.3% solution in cataract surgery patients. , 2005, Ophthalmology.
[5] D. Stroman,et al. In vitro and in vivo potency of moxifloxacin and moxifloxacin ophthalmic solution 0.5%, a new topical fluoroquinolone. , 2005, Survey of ophthalmology.
[6] K. Ramasamy,et al. Postcataract endophthalmitis in South India incidence and outcome. , 2005, Ophthalmology.
[7] A. Behrens,et al. The incidence of endophthalmitis after cataract surgery among the U.S. Medicare population increased between 1994 and 2001. , 2005, Ophthalmology.
[8] H. Flynn,et al. Acute-onset endophthalmitis after cataract surgery (2000-2004): incidence, clinical settings, and visual acuity outcomes after treatment. , 2005, American journal of ophthalmology.
[9] A. Behrens,et al. Acute endophthalmitis following cataract surgery: a systematic review of the literature. , 2005, Archives of ophthalmology.
[10] M. Blumenkranz,et al. Antibiotic susceptibility of preoperative normal conjunctival bacteria. , 2005, American journal of ophthalmology.
[11] A. Ho,et al. Changing trends in the microbiologic aspects of postcataract endophthalmitis. , 2005, Archives of ophthalmology.
[12] C. Nedrud,et al. Penetration of topically applied gatifloxacin 0.3%, moxifloxacin 0.5%, and ciprofloxacin 0.3% into the aqueous humor. , 2004, Ophthalmology.
[13] D. Hwang. Fluoroquinolone resistance in ophthalmology and the potential role for newer ophthalmic fluoroquinolones. , 2004, Survey of ophthalmology.
[14] R. Olson. Reducing the risk of postoperative endophthalmitis. , 2004, Survey of ophthalmology.
[15] F. Bucci. An in vivo study comparing the ocular absorption of levofloxacin and ciprofloxacin prior to phacoemulsification. , 2004, American journal of ophthalmology.
[16] E. Romanowski,et al. Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates. , 2003, American journal of ophthalmology.
[17] P. Thompson,et al. Case-control study of endophthalmitis after cataract surgery comparing scleral tunnel and clear corneal wounds. , 2003, American journal of ophthalmology.
[18] Zhongping Chen,et al. Dynamic morphology of clear corneal cataract incisions. , 2003, Ophthalmology.
[19] Patrick J. Heagerty. Analysis of Longitudinal Data , 2003 .
[20] M. Blumenkranz,et al. Prospective randomized comparison of 3-day versus 1-hour preoperative ofloxacin prophylaxis for cataract surgery. , 2002, Ophthalmology.
[21] R. Tandon,et al. Topical ciprofloxacin‐dexamethasone combination therapy after cataract surgery: randomized controlled clinical trial , 2001, Journal of cataract and refractive surgery.
[22] T. Liesegang. Use of antimicrobials to prevent postoperative infection in patients with cataracts. , 2001, Current opinion in ophthalmology.
[23] W. Hamilton,et al. Effect of prophylactic antibiotics and incision type on the incidence of endophthalmitis after cataract surgery. , 2000, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.
[24] U. Ransjö,et al. Preoperative Gentamicin Eye Drops and Chlorhexidine Solution in Cataract Surgery. Experimental and Clinical Results , 2000, European journal of ophthalmology.
[25] G. Alexandrakis,et al. Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones. , 2000, Ophthalmology.
[26] T. Das,et al. Microbiologic spectrum and susceptibility of isolates: part II. Posttraumatic endophthalmitis. Endophthalmitis Research Group. , 1999, American journal of ophthalmology.
[27] T. Das,et al. Microbiologic spectrum and susceptibility of isolates: part I. Postoperative endophthalmitis. Endophthalmitis Research Group. , 1999, American journal of ophthalmology.
[28] J. Baum,et al. Emerging fluoroquinolone resistance in bacterial keratitis: A 5-year review , 1999 .
[29] H. Flynn,et al. Nosocomial acute-onset postoperative endophthalmitis survey. A 10-year review of incidence and outcomes. , 1998, Ophthalmology.
[30] S. Wisniewski,et al. Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study. , 1996, American journal of ophthalmology.
[31] J C Javitt,et al. National outcomes of cataract extraction. Endophthalmitis following inpatient surgery. , 1991, Archives of ophthalmology.
[32] B. Kreiswirth,et al. Role of external bacterial flora in the pathogenesis of acute postoperative endophthalmitis. , 1991, Ophthalmology.
[33] J. Ware,et al. Random-effects models for longitudinal data. , 1982, Biometrics.
[34] A. Crandall,et al. A retrospective study of endophtalmitis rates comparing quinolone antibiotics. , 2005, American journal of ophthalmology.
[35] G. van Rij,et al. Incidence of endophthalmitis after cataract surgery in the Netherlands , 2004, Documenta Ophthalmologica.
[36] G. Belle. Statistical rules of thumb , 2002 .
[37] R. Kowalski,et al. Emerging fluoroquinolone resistance in bacterial keratitis: a 5-year review. , 1999, Ophthalmology.
[38] T. A. Bell,et al. The effect of trimethoprim-polymyxin B sulphate ophthalmic ointment and chloramphenicol ophthalmic ointment on the bacterial flora of the eye when administered to the operated and unoperated eyes of patients undergoing cataract surgery , 1988, Eye.